home / stock / aldx / aldx quote
Last: | $4.15 |
---|---|
Change Percent: | -2.2% |
Open: | $4.18 |
Close: | $4.15 |
High: | $4.21 |
Low: | $4.0845 |
Volume: | 195,735 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.15 | $4.18 | $4.15 | $4.21 | $4.0845 | 195,735 | 07-26-2024 |
$4.09 | $3.94 | $4.09 | $4.1 | $3.9399 | 228,981 | 07-25-2024 |
$3.91 | $4.01 | $3.91 | $4.08 | $3.89 | 249,875 | 07-24-2024 |
$4.01 | $3.86 | $4.01 | $4.11 | $3.8256 | 256,560 | 07-23-2024 |
$3.87 | $3.87 | $3.87 | $3.96 | $3.77 | 209,729 | 07-22-2024 |
$3.82 | $3.87 | $3.82 | $3.96 | $3.81 | 187,651 | 07-19-2024 |
$3.87 | $4.04 | $3.87 | $4.2 | $3.85 | 223,959 | 07-18-2024 |
$4.07 | $4.21 | $4.07 | $4.36 | $3.99 | 402,615 | 07-17-2024 |
$4.3 | $4 | $4.3 | $4.39 | $3.99 | 600,118 | 07-16-2024 |
$3.96 | $3.86 | $3.96 | $3.97 | $3.73 | 218,711 | 07-15-2024 |
$3.86 | $3.7 | $3.86 | $3.94 | $3.68 | 320,190 | 07-12-2024 |
$3.64 | $3.42 | $3.64 | $3.71 | $3.42 | 336,023 | 07-11-2024 |
$3.4 | $3.41 | $3.4 | $3.45 | $3.3 | 123,504 | 07-10-2024 |
$3.4 | $3.31 | $3.4 | $3.59 | $3.31 | 250,279 | 07-09-2024 |
$3.31 | $3.21 | $3.31 | $3.34 | $3.2 | 240,083 | 07-08-2024 |
$3.19 | $3.2 | $3.19 | $3.2 | $3.1 | 221,582 | 07-05-2024 |
$3.2 | $3.22 | $3.2 | $3.3 | $3.15 | 164,575 | 07-04-2024 |
$3.2 | $3.22 | $3.2 | $3.3 | $3.15 | 164,575 | 07-03-2024 |
$3.25 | $3.28 | $3.25 | $3.29 | $3.16 | 238,595 | 07-02-2024 |
$3.25 | $3.28 | $3.25 | $3.38 | $3.21 | 295,450 | 07-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
Live Webcast Scheduled to Begin at 8:00 a.m. ET Today Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced advancement of new ...
Clinical Trial Results and Potential New Drug Application Resubmission Expected in the Second Half of 2024 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabo...
Event Scheduled for Thursday, June 20 at 8:00 a.m. ET Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that the company will h...